A recent article in Forbes described why a promising academic doctor at Stanford left to start his own company. This is not, by any means, the first time we have heard about doctors or doctors-to-be leaving clinical medicine for “all-in” entrepreneurship, nor the first time we’ve heard debated whether that is a good idea or not.

One reason I've heard more than once from both faculty and community stakeholders is the difficulties working with a university technology transfer (OTT) or Office of Technology Licensing (OTL), such as the one at Stanford.